And how about SammyJo's new book:

"
By Elaine Moore, co-author SammyJo Wilkinson
Foreword by Dr. Yash Agrawal, MD, PhD

The off-label protocol referred to as Low Dose Naltrexone (LDN) modulates the immune system and promotes healing. Relying on clinical trial results and interviews with the leading LDN researchers worldwide, we describe the history of LDN and explain its biochemical and molecular effects. In clinical trials, LDN has been shown to halt disease progression in Crohn’s disease and certain cancers, including pancreatic cancer, and to reduce symptoms in multiple sclerosis (MS) and autism. Ongoing trials are evaluating LDN in fibromyalgia and HIV/AIDS. Anecdotally, LDN has been shown to improve almost every autoimmune and neurodegenerative condition, including Parkinson’s disease and amyotrophic lateral sclerosis (ALS).

Chapter One The War on Drugs, A History of Naltrexone
Chapter Two LDN in Autoimmune Diseases
Chapter Three LDN in Multiple Sclerosis
Chapter Four LDN in Neurodegenerative Disorders
Chapter Five LDN in Cancer
Chapter Six LDN in Autism Spectrum Disorders
Chapter Seven LDN in Wound Healing and Infections
Chapter Eight The Immune System and LDN in HIV/AIDS
Chapter Nine The LDN Experience: A Patient’s Guide to LDN
Chapter Ten The Potential Benefits and Future of LDN
Chapter Eleven Resources
Appendix A LDN Clinical Trials
Appendix B LDN Survey
Appendix C LDN Survey Analysis

A BIG thank you to Elaine Moore for making this book a reality. She is an extensively published author on autoimmune disorders. This book will be an invaluable reference for researchers, practitioners and patients who want to understand the therapeutic potential of LDN."

http://www.ldners.org/

Cherie